StockData

ASP Isotopes vs Jaguar Health

ASPI and JAGX side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How ASPI and JAGX compare

ASP Isotopes is the larger company, worth 104 times as much as Jaguar Health ($210M against $2.0M).

ASP Isotopes grew revenue faster over the last twelve months (573% versus 136% for Jaguar Health).

ASP Isotopes scores higher on the StockData Score (6 against 3 for Jaguar Health), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricASPIJAGX
Size and price
Market cap$210M$2.0M
Share price$1.37$0.390
Change, 1 year−83.1%−100.0%
Change, 5 years–−100%
Beta (5Y)3.005.30
Employees27147
StockData Score
Total score6 (better)3
Valuation score3 (better)1
Growth score12 (better)
Performance score00
Health score2 (better)0
Dividend score00
Valuation
P/S6.8×0.1× (better)
P/B0.8×–
FCF yield−39.8%–
Fair value$5.20–
Margin of safety73.7%–
Growth
Revenue growth (TTM)573% (better)136%
Revenue growth, 5Y average–4.2%
Profitability
Gross margin18.3%82.3% (better)
Operating margin−321%−93.1% (better)
Net margin−380%–
FCF margin−271%–
Return on equity−80.9%–
Return on invested capital−549%–
Financial health
Debt / equity0.23–
Interest coverage−25.3× (better)−25.9×
Current ratio3.87 (better)0.69
Altman Z-score−0.34 (better)−18.45
Piotroski F-score4 (better)2
Dividends and buybacks
Shareholder yield0.00%0.00%
Ownership
Held by institutions42.7%–
Held by insiders10.7%17.1%
Insider net buying, 12 months−$7.7M–
Short interest, % of float22.9%4.7%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.